Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.

Nissen C, Feige B, Nofzinger E, Riemann D, Berger M, Voderholzer U.

J Sleep Res. 2005 Jun;14(2):207-8. No abstract available.

2.

Venlafaxine withdrawal symptoms.

Benazzi F.

Can J Psychiatry. 1996 Sep;41(7):487. No abstract available.

PMID:
8884044
3.

Antidepressant efficacy of venlafaxine.

Golden RN, Nicholas L.

Depress Anxiety. 2000;12 Suppl 1:45-9. Review.

PMID:
11098413
4.

Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?

Amsterdam JD, Shults J.

J Affect Disord. 2009 May;115(1-2):234-40. doi: 10.1016/j.jad.2008.07.007.

PMID:
18694599
5.

Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.

Liau CH, Shen WW, Su KP.

Psychiatry Clin Neurosci. 2006 Feb;60(1):121-2. No abstract available.

6.

Withdrawal reactions associated with venlafaxine.

Parker G, Blennerhassett J.

Aust N Z J Psychiatry. 1998 Apr;32(2):291-4.

PMID:
9588310
7.

Venlafaxine withdrawal syndrome.

Sabljić V, Ružić K, Rakun R.

Psychiatr Danub. 2011 Mar;23(1):117-9.

8.

Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.

Dallal A, Chouinard G.

J Clin Psychopharmacol. 1998 Aug;18(4):343-4. No abstract available.

PMID:
9690703
9.

Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.

Gitlin MJ.

J Clin Psychopharmacol. 1997 Feb;17(1):66-7. No abstract available.

PMID:
9004070
10.

Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.

Koga M, Kodaka F, Miyata H, Nakayama K.

Acta Psychiatr Scand. 2009 Oct;120(4):329-31. doi: 10.1111/j.1600-0447.2009.01433.x.

11.

Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.

Haddad PM, Devarajan S, Dursun SM.

J Psychopharmacol. 2001 Jun;15(2):139-41.

PMID:
11448088
12.

Venlafaxine-associated mania.

Shulman RB, Scheftner WA, Nayudu S.

J Clin Psychopharmacol. 2001 Apr;21(2):239-41. No abstract available.

PMID:
11270924
13.

Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.

Møller LR, Østergaard JR.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):197-201. doi: 10.1089/cap.2008.036.

PMID:
19364297
14.

[Hypomania/mania induced by cessation of antidepressant drugs].

Kora K, Kaplan P.

Turk Psikiyatri Derg. 2008 Fall;19(3):329-33. Turkish.

15.

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T.

J Clin Psychiatry. 2005 Oct;66(10):1312-20.

PMID:
16259546
16.

Shock-like sensations during venlafaxine withdrawal.

Reeves RR, Mack JE, Beddingfield JJ.

Pharmacotherapy. 2003 May;23(5):678-81.

PMID:
12741444
17.

Fluoxetine discontinuation in elderly dysthymic patients.

Devanand DP, Kim MK, Nobler MS.

Am J Geriatr Psychiatry. 1997 Winter;5(1):83-7.

PMID:
9169249
18.
19.

Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.

Baboolal NS.

J Clin Psychopharmacol. 2004 Apr;24(2):229-31. No abstract available.

PMID:
15206672
20.

Knowledge of and attitudes towards depression and adherence to treatment: the Antidepressant Adherence Scale (AAS).

Gabriel A, Violato C.

J Affect Disord. 2010 Nov;126(3):388-94. doi: 10.1016/j.jad.2010.07.013.

PMID:
20708273
Items per page

Supplemental Content

Support Center